Sanginita Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 20, 2026.
SANGINITA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The board of Sanginita Chemicals has approved issuing up to 1,52,87,356 equity shares at Rs. 13.05 each (face value Rs. 10, premium Rs. 3.05) totalling about Rs. 19.95 crore as a share swap to acquire 95 lakh equity shares of Agastya Green Energy Limited (AGEL), making AGEL a wholly owned subsidiary. Separately, the board also approved a cash preferential issue of up to 1,91,57,080 equity shares at Rs. 13.05 each (about Rs. 25 crore) to the same allottee, BNG Investment LLC. Post-allotment, BNG Investment LLC will hold around 64.66% of the expanded share capital, gaining majority control. The move signals a major diversification from the company's existing chemicals business into solar panel/cell manufacturing, EPC, and power generation, even though AGEL reported nil turnover as of November 2025 and was incorporated only in March 2025.
Existing public shareholders will see significant dilution as the promoter/allottee group's stake rises to nearly two-thirds of the company. The acquisition of a newly incorporated, zero-revenue entity in a different sector carries execution and valuation risk, though the company positions it as a strategic entry into renewable energy.